Skip to content

References

The consolidated source list for this platform. Every research record, guideline record and evidence claim traces to a published source listed here or in the Research Database.

Systematic reviews and meta-analyses

  1. Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. 2012. DOI: 10.1002/14651858.CD000146.pub4
  2. Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-analyses. Cochrane Database Syst Rev. 2013. DOI: 10.1002/14651858.CD009329.pub2
  3. Cahill K, Stevens S, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev. 2013 (2016 update). DOI: 10.1002/14651858.CD006103.pub4
  4. Hughes JR, Stead LF, Hartmann-Boyce J, et al. Antidepressants for smoking cessation. Cochrane Database Syst Rev. 2014. DOI: 10.1002/14651858.CD000031.pub3
  5. Lindson-Hawley N, Aveyard P, Hughes JR. Reduction versus abrupt cessation in smokers who want to quit. Cochrane Database Syst Rev. 2016. DOI: 10.1002/14651858.CD010332.pub2
  6. Lindson N, Butler AR, McRobbie H, et al. Electronic cigarettes for smoking cessation (living systematic review). Cochrane Database Syst Rev. 2024. DOI: 10.1002/14651858.CD010216.pub8 · PMID: 38189560

Randomized trials

  1. Hajek P, Phillips-Waller A, Przulj D, et al. A randomized trial of e-cigarettes versus nicotine-replacement therapy. N Engl J Med. 2019. DOI: 10.1056/NEJMoa1808779
  2. Anthenelli RM, Benowitz NL, West R, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES). Lancet. 2016. DOI: 10.1016/S0140-6736(16)30272-0
  3. West R, Zatonski W, Cedzynska M, et al. Placebo-controlled trial of cytisine for smoking cessation. N Engl J Med. 2011. DOI: 10.1056/NEJMoa1102035
  4. Walker N, Howe C, Glover M, et al. Cytisine versus nicotine for smoking cessation. N Engl J Med. 2014. DOI: 10.1056/NEJMoa1407764

Cohort studies and reviews

  1. Jha P, Ramasundarahettige C, Landsman V, et al. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med. 2013. DOI: 10.1056/NEJMsa1211128
  2. Hughes JR. Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob Res. 2007. DOI: 10.1080/14622200701188919

Guidelines and public-health sources

  1. World Health Organization. WHO clinical treatment guideline for tobacco cessation in adults. Geneva: WHO; 2024. ISBN: 9789240096431. who.int
  2. US Preventive Services Task Force. Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Recommendation Statement. JAMA. 2021;325(3):265-279. DOI: 10.1001/jama.2020.25019
  3. National Institute for Health and Care Excellence. Tobacco: preventing uptake, promoting quitting and treating dependence. NG209. 2021 (last reviewed 2025). nice.org.uk
  4. US Public Health Service. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline.
  5. US Department of Health and Human Services. Smoking Cessation: A Report of the Surgeon General. 2020.
  6. World Health Organization. Tobacco fact sheet (health effects and cessation). 2023.

Sourcing policy

  • All DOIs above are real and link to the published record.
  • Community experience data (experience database, relapse reports, patterns) are attributed to the de-identified ingestion pipeline described in the main-site methodology — they are not part of the scientific evidence base and are never cited as such.
  • Sources are re-verified against the publisher when records are updated; each research record carries a last-verified date.